citalopram and 3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide

citalopram has been researched along with 3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baranowska-Kuczko, M; Göthert, M; Kloza, M; Kozłowska, H; Kozłowski, M; MacLean, MR; Malinowska, B; Sadowska, O; Schlicker, E	1

Other Studies

1 other study(ies) available for citalopram and 3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide

Article	Year
Reduction of the serotonin 5-HT Pharmacological reports : PR, 2020, Volume: 72, Issue:3 Topics: Aged; Benzamides; Citalopram; Cyclic S-Oxides; Female; Humans; Male; Middle Aged; Piperidones; Pulmonary Artery; Pyridines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Spiro Compounds; Thiadiazines; Vasoconstriction	2020

Article

Year

Reduction of the serotonin 5-HT

Pharmacological reports : PR, 2020, Volume: 72, Issue:3

Topics: Aged; Benzamides; Citalopram; Cyclic S-Oxides; Female; Humans; Male; Middle Aged; Piperidones; Pulmonary Artery; Pyridines; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Spiro Compounds; Thiadiazines; Vasoconstriction

2020